Literature DB >> 25958743

An atypical addition to the chemokine receptor nomenclature: IUPHAR Review 15.

Françoise Bachelerie1, Gerard J Graham2, Massimo Locati3,4, Alberto Mantovani3,4, Philip M Murphy5, Robert Nibbs2, Antal Rot6, Silvano Sozzani4,7, Marcus Thelen8.   

Abstract

Chemokines and their receptors are essential regulators of in vivo leukocyte migration and, some years ago, a systematic nomenclature system was developed for the chemokine receptor family. Chemokine receptor biology and biochemistry was recently extensively reviewed. In this review, we also highlighted a new component to the nomenclature system that incorporates receptors previously known as 'scavenging', or 'decoy', chemokine receptors on the basis of their lack of classical signalling responses to ligand binding and their general ability to scavenge, or sequester, their cognate chemokine ligands. These molecules are now collectively referred to as 'atypical chemokine receptors', or ACKRs, and play fundamental roles in regulating in vivo responses to chemokines. This commentary highlights this new addition to the chemokine receptor nomenclature system and provides brief information on the four receptors currently covered by this nomenclature.
© 2015 The British Pharmacological Society.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25958743      PMCID: PMC4543604          DOI: 10.1111/bph.13182

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  29 in total

Review 1.  The biochemistry and biology of the atypical chemokine receptors.

Authors:  G J Graham; M Locati; A Mantovani; A Rot; M Thelen
Journal:  Immunol Lett       Date:  2012-07-30       Impact factor: 3.685

2.  CCL19 is a specific ligand of the constitutively recycling atypical human chemokine receptor CRAM-B.

Authors:  Marion Leick; Julie Catusse; Marie Follo; Robert J Nibbs; Tanja N Hartmann; Hendrik Veelken; Meike Burger
Journal:  Immunology       Date:  2009-12-02       Impact factor: 7.397

Review 3.  Chemokine sequestration by atypical chemokine receptors.

Authors:  C A H Hansell; C V Simpson; R J B Nibbs
Journal:  Biochem Soc Trans       Date:  2006-12       Impact factor: 5.407

Review 4.  Current understanding of stem cell mobilization: the roles of chemokines, proteolytic enzymes, adhesion molecules, cytokines, and stromal cells.

Authors:  Tsvee Lapidot; Isabelle Petit
Journal:  Exp Hematol       Date:  2002-09       Impact factor: 3.084

5.  The Duffy antigen receptor for chemokines transports chemokines and supports their promigratory activity.

Authors:  Monika Pruenster; Liesbeth Mudde; Paula Bombosi; Svetla Dimitrova; Marion Zsak; Jim Middleton; Ann Richmond; Gerard J Graham; Stephan Segerer; Robert J B Nibbs; Antal Rot
Journal:  Nat Immunol       Date:  2008-12-07       Impact factor: 25.606

6.  Modulation of circadian glucocorticoid oscillation via adrenal opioid-CXCR7 signaling alters emotional behavior.

Authors:  Yuichi Ikeda; Hidetoshi Kumagai; Amber Skach; Makito Sato; Masashi Yanagisawa
Journal:  Cell       Date:  2013-12-05       Impact factor: 41.582

Review 7.  The chemokine and chemokine receptor superfamilies and their molecular evolution.

Authors:  Albert Zlotnik; Osamu Yoshie; Hisayuki Nomiyama
Journal:  Genome Biol       Date:  2006       Impact factor: 13.583

Review 8.  International Union of Basic and Clinical Pharmacology. [corrected]. LXXXIX. Update on the extended family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors.

Authors:  Francoise Bachelerie; Adit Ben-Baruch; Amanda M Burkhardt; Christophe Combadiere; Joshua M Farber; Gerard J Graham; Richard Horuk; Alexander Hovard Sparre-Ulrich; Massimo Locati; Andrew D Luster; Alberto Mantovani; Kouji Matsushima; Philip M Murphy; Robert Nibbs; Hisayuki Nomiyama; Christine A Power; Amanda E I Proudfoot; Mette M Rosenkilde; Antal Rot; Silvano Sozzani; Marcus Thelen; Osamu Yoshie; Albert Zlotnik
Journal:  Pharmacol Rev       Date:  2013-11-11       Impact factor: 25.468

9.  Duffy antigen receptor for chemokines and its involvement in patterning and control of inflammatory chemokines.

Authors:  Igor Novitzky-Basso; Antal Rot
Journal:  Front Immunol       Date:  2012-08-17       Impact factor: 7.561

10.  The IUPHAR/BPS Guide to PHARMACOLOGY: an expert-driven knowledgebase of drug targets and their ligands.

Authors:  Adam J Pawson; Joanna L Sharman; Helen E Benson; Elena Faccenda; Stephen P H Alexander; O Peter Buneman; Anthony P Davenport; John C McGrath; John A Peters; Christopher Southan; Michael Spedding; Wenyuan Yu; Anthony J Harmar
Journal:  Nucleic Acids Res       Date:  2013-11-14       Impact factor: 16.971

View more
  15 in total

1.  Design, Synthesis, and Characterization of Ogerin-Based Positive Allosteric Modulators for G Protein-Coupled Receptor 68 (GPR68).

Authors:  Xufen Yu; Xi-Ping Huang; Terry P Kenakin; Samuel T Slocum; Xin Chen; Michael L Martini; Jing Liu; Jian Jin
Journal:  J Med Chem       Date:  2019-08-01       Impact factor: 7.446

Review 2.  Chemokine and chemotactic signals in dendritic cell migration.

Authors:  Laura Tiberio; Annalisa Del Prete; Tiziana Schioppa; Francesca Sozio; Daniela Bosisio; Silvano Sozzani
Journal:  Cell Mol Immunol       Date:  2018-03-21       Impact factor: 11.530

Review 3.  Structural Analysis of Chemokine Receptor-Ligand Interactions.

Authors:  Marta Arimont; Shan-Liang Sun; Rob Leurs; Martine Smit; Iwan J P de Esch; Chris de Graaf
Journal:  J Med Chem       Date:  2017-03-10       Impact factor: 7.446

4.  Ligand-specific conformational transitions and intracellular transport are required for atypical chemokine receptor 3-mediated chemokine scavenging.

Authors:  Nicolas Montpas; Geneviève St-Onge; Nassr Nama; David Rhainds; Besma Benredjem; Mélanie Girard; Gilles Hickson; Véronique Pons; Nikolaus Heveker
Journal:  J Biol Chem       Date:  2017-11-27       Impact factor: 5.157

Review 5.  International Union of Basic and Clinical Pharmacology CIII: Chemerin Receptors CMKLR1 (Chemerin1) and GPR1 (Chemerin2) Nomenclature, Pharmacology, and Function.

Authors:  Amanda J Kennedy; Anthony P Davenport
Journal:  Pharmacol Rev       Date:  2017-12-26       Impact factor: 25.468

Review 6.  Advances in Biomarker-Guided Therapy for Pediatric- and Adult-Onset Neuroinflammatory Disorders: Targeting Chemokines/Cytokines.

Authors:  Michael R Pranzatelli
Journal:  Front Immunol       Date:  2018-04-04       Impact factor: 7.561

7.  Yeast surface display identifies a family of evasins from ticks with novel polyvalent CC chemokine-binding activities.

Authors:  Kamayani Singh; Graham Davies; Yara Alenazi; James R O Eaton; Akane Kawamura; Shoumo Bhattacharya
Journal:  Sci Rep       Date:  2017-06-27       Impact factor: 4.379

Review 8.  Neutrophils: Beneficial and Harmful Cells in Septic Arthritis.

Authors:  Daiane Boff; Helena Crijns; Mauro M Teixeira; Flavio A Amaral; Paul Proost
Journal:  Int J Mol Sci       Date:  2018-02-05       Impact factor: 5.923

Review 9.  The Role of CCL21/CCR7 Chemokine Axis in Breast Cancer Progression.

Authors:  Balsam Rizeq; Mohammed Imad Malki
Journal:  Cancers (Basel)       Date:  2020-04-23       Impact factor: 6.639

Review 10.  Teleost Chemokines and Their Receptors.

Authors:  Steve Bird; Carolina Tafalla
Journal:  Biology (Basel)       Date:  2015-11-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.